Original Research
Published on 02 Feb 2023
The level of kinesiophobia in breast cancer women undergoing surgical treatment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1010315
- 5,830 views
- 12 citations
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
662 articles
Original Research
Published on 02 Feb 2023
Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1046774
- 2,147 views
- 4 citations
Systematic Review
Published on 02 Feb 2023
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1100332
- 3,475 views
- 12 citations
Original Research
Published on 01 Feb 2023
Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1071076
- 2,571 views
- 4 citations
Original Research
Published on 31 Jan 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1028825
- 2,401 views
- 5 citations
Original Research
Published on 31 Jan 2023
The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1081201
- 2,583 views
- 1 citation
Review
Published on 30 Jan 2023
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1083297
- 4,763 views
- 7 citations
Original Research
Published on 30 Jan 2023
The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1041111
- 2,880 views
Original Research
Published on 30 Jan 2023
Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1002186
- 4,880 views
- 10 citations
Review
Published on 27 Jan 2023
Correlation between the Warburg effect and progression of triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1060495
- 10,449 views
- 24 citations
Original Research
Published on 26 Jan 2023
A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1035645
- 1,753 views
- 1 citation
Original Research
Published on 25 Jan 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.978985
- 5,919 views
- 17 citations
Review
Published on 25 Jan 2023
Emerging functions of C/EBPβ in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1111522
- 6,231 views
- 22 citations
Case Report
Published on 25 Jan 2023
Breast metastasis from endometrial clear cell carcinoma: A case report and review of the literature
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1070744
- 3,762 views
- 5 citations
Systematic Review
Published on 24 Jan 2023
LAG-3+ tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.986903
- 3,520 views
- 8 citations
Original Research
Published on 24 Jan 2023
Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 & XRCC3 and risk of breast cancer: A meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1047336
- 2,967 views
- 6 citations